Press Release

Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives

Agreement marks achievement of Cerenome’s full-year 2026 commercial payer coverage objective for CNSide HOUSTON, Aug. 13, 2026 (GLOBE NEWSWIRE) — CNSide Diagnostics, LLC, a wholly-owned subsidiary of Cerenome, Inc.  (Nasdaq:  CNSY) (“Cerenome” or the “Company”), announced today that it has signed…